Human Papillomavirus Testing Market

Human Papillomavirus Testing Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

The human papillomavirus testing market is anticipated to expand at a CAGR of 12.5% between 2023 to 2032.

The human papillomavirus testing market size was estimated to be US$ 850 million in 2021.

Abbott Labs., Biomedical Diagnostics Inc., bioMerieux, Bio-Rad, Epigenomics, Gen-Probe, OncoLab, Radient Pharmaceuticals, Roche, Sequenom, Siemens Healthcare, and Qiagen, are market leaders in HPV testing.

Human papillomavirus testing is primarily used to detect the presence of HPV in patients with a high risk of cervical cancer.

Increasing awareness of the link between cervical cancer along with the increasing prevalence of cervical cancer among the female population is driving the growth of the global HPV testing market.

The HPV testing market is largely based in the North America region. Increased awareness of diagnostic techniques has resulted in a demand for early diagnosis, especially in the USA and Canada.